US Stock MarketDetailed Quotes

Vera Therapeutics (VERA)

Watchlist
  • 47.330
  • -1.385-2.84%
Trading Jan 23 10:46 ET
3.32BMarket Cap-11.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vera Therapeutics (VERA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
68.53%83.93M
114.61%80.14M
83.83%57.19M
63.87%167.17M
80.98%48.91M
128.91%49.8M
69.97%37.34M
-0.47%31.11M
12.22%102.01M
-19.51%27.03M
Selling and administrative expenses
189.44%27.46M
173.23%21.95M
101.16%15.92M
72.35%41M
149.35%15.57M
67.73%9.49M
39.95%8.03M
28.65%7.91M
8.57%23.79M
-9.59%6.24M
-Selling and marketing expense
142,525.00%5.71M
190,450.00%3.81M
5,038.46%1.34M
----
----
--4K
--2K
--26K
----
----
-General and administrative expense
129.40%21.75M
125.84%18.14M
84.88%14.58M
72.35%41M
149.86%15.6M
67.66%9.48M
39.92%8.03M
28.23%7.89M
8.57%23.79M
-9.59%6.24M
Research and development costs
40.08%56.47M
98.54%58.2M
77.92%41.28M
61.29%126.17M
60.44%33.35M
150.40%40.31M
80.59%29.31M
-7.60%23.2M
13.38%78.23M
-22.08%20.79M
Operating profit
-68.53%-83.93M
-114.61%-80.14M
-83.83%-57.19M
-63.87%-167.17M
-80.98%-48.91M
-128.91%-49.8M
-69.97%-37.34M
0.47%-31.11M
-12.22%-102.01M
19.51%-27.03M
Net non-operating interest income expense
33.66%3.78M
39.29%4.45M
124.30%5.11M
212.14%13.09M
430.09%4.79M
132.51%2.83M
140.91%3.19M
204.41%2.28M
453.17%4.19M
206.44%904K
Non-operating interest income
20.48%5.74M
23.82%6.32M
64.98%6.91M
159.61%20.71M
239.95%6.66M
120.62%4.76M
127.96%5.1M
157.92%4.19M
355.94%7.98M
119.24%1.96M
Non-operating interest expense
1.24%1.96M
-1.99%1.87M
-5.98%1.79M
101.43%7.63M
77.18%1.87M
105.30%1.94M
109.19%1.91M
118.08%1.91M
281.65%3.79M
76.29%1.06M
Other net income (expense)
-139.83%-137K
-288.71%-836K
-14.03%386K
5.74%1.94M
48.51%698K
-21.28%344K
-8.28%443K
2.05%449K
67.89%1.83M
-44.58%470K
Gain on sale of security
----
----
----
----
----
----
75.00%-7K
-300.00%-4K
----
----
Other non- operating income (expenses)
-139.83%-137K
-288.71%-836K
-14.03%386K
5.74%1.94M
48.51%698K
-21.28%344K
-13.31%443K
1.81%449K
-3.63%1.83M
-48.46%470K
Income before tax
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.42M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.65M
Income tax
0.00%1K
0.00%1K
Net income
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
Net income continuous Operations
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
Minority interest income
Net income attributable to the parent company
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-72.18%-80.29M
-127.04%-76.53M
-82.13%-51.69M
-58.50%-152.15M
-69.27%-43.43M
-131.95%-46.63M
-67.19%-33.71M
5.61%-28.38M
-7.79%-95.99M
20.91%-25.66M
Basic earnings per share
-48.24%-1.26
-93.55%-1.2
-44.64%-0.81
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
30.00%-0.56
32.84%-2.25
51.26%-0.58
Diluted earnings per share
-48.24%-1.26
-93.55%-1.2
-44.64%-0.81
-22.22%-2.75
-24.14%-0.72
-88.89%-0.85
-34.78%-0.62
30.00%-0.56
32.84%-2.25
51.26%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 68.53%83.93M114.61%80.14M83.83%57.19M63.87%167.17M80.98%48.91M128.91%49.8M69.97%37.34M-0.47%31.11M12.22%102.01M-19.51%27.03M
Selling and administrative expenses 189.44%27.46M173.23%21.95M101.16%15.92M72.35%41M149.35%15.57M67.73%9.49M39.95%8.03M28.65%7.91M8.57%23.79M-9.59%6.24M
-Selling and marketing expense 142,525.00%5.71M190,450.00%3.81M5,038.46%1.34M----------4K--2K--26K--------
-General and administrative expense 129.40%21.75M125.84%18.14M84.88%14.58M72.35%41M149.86%15.6M67.66%9.48M39.92%8.03M28.23%7.89M8.57%23.79M-9.59%6.24M
Research and development costs 40.08%56.47M98.54%58.2M77.92%41.28M61.29%126.17M60.44%33.35M150.40%40.31M80.59%29.31M-7.60%23.2M13.38%78.23M-22.08%20.79M
Operating profit -68.53%-83.93M-114.61%-80.14M-83.83%-57.19M-63.87%-167.17M-80.98%-48.91M-128.91%-49.8M-69.97%-37.34M0.47%-31.11M-12.22%-102.01M19.51%-27.03M
Net non-operating interest income expense 33.66%3.78M39.29%4.45M124.30%5.11M212.14%13.09M430.09%4.79M132.51%2.83M140.91%3.19M204.41%2.28M453.17%4.19M206.44%904K
Non-operating interest income 20.48%5.74M23.82%6.32M64.98%6.91M159.61%20.71M239.95%6.66M120.62%4.76M127.96%5.1M157.92%4.19M355.94%7.98M119.24%1.96M
Non-operating interest expense 1.24%1.96M-1.99%1.87M-5.98%1.79M101.43%7.63M77.18%1.87M105.30%1.94M109.19%1.91M118.08%1.91M281.65%3.79M76.29%1.06M
Other net income (expense) -139.83%-137K-288.71%-836K-14.03%386K5.74%1.94M48.51%698K-21.28%344K-8.28%443K2.05%449K67.89%1.83M-44.58%470K
Gain on sale of security ------------------------75.00%-7K-300.00%-4K--------
Other non- operating income (expenses) -139.83%-137K-288.71%-836K-14.03%386K5.74%1.94M48.51%698K-21.28%344K-13.31%443K1.81%449K-3.63%1.83M-48.46%470K
Income before tax -72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.42M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.65M
Income tax 0.00%1K0.00%1K
Net income -72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M
Net income continuous Operations -72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M
Minority interest income
Net income attributable to the parent company -72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -72.18%-80.29M-127.04%-76.53M-82.13%-51.69M-58.50%-152.15M-69.27%-43.43M-131.95%-46.63M-67.19%-33.71M5.61%-28.38M-7.79%-95.99M20.91%-25.66M
Basic earnings per share -48.24%-1.26-93.55%-1.2-44.64%-0.81-22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.6230.00%-0.5632.84%-2.2551.26%-0.58
Diluted earnings per share -48.24%-1.26-93.55%-1.2-44.64%-0.81-22.22%-2.75-24.14%-0.72-88.89%-0.85-34.78%-0.6230.00%-0.5632.84%-2.2551.26%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.15%
Sample Name
Sample Code
 +2.78%
Sample Name
Sample Code
 +1.93%
4
Netflix
NFLX
+1.83%
5
NVIDIA
NVDA
+1.67%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.21%
Sample Name
Sample Code
 +8.74%
Sample Name
Sample Code
 +4.35%
4
KE Holdings
BEKE
+4.16%
5
H World Group
HTHT
+4.14%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -